Ardent Health Partners (NYSE:ARDT) Price Target Lowered to $21.00 at Truist Financial

Ardent Health Partners (NYSE:ARDTGet Free Report) had its target price lowered by stock analysts at Truist Financial from $22.00 to $21.00 in a note issued to investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Truist Financial’s price objective would suggest a potential upside of 26.20% from the company’s current price.

Other research analysts have also recently issued reports about the company. Bank of America cut Ardent Health Partners from a “buy” rating to a “neutral” rating and reduced their price target for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a research note on Tuesday, December 17th. KeyCorp began coverage on shares of Ardent Health Partners in a research report on Friday, October 11th. They set an “overweight” rating and a $24.00 price target on the stock. Royal Bank of Canada reiterated an “outperform” rating and issued a $23.00 price objective on shares of Ardent Health Partners in a research report on Thursday, November 14th. Finally, Stephens restated an “overweight” rating and set a $24.00 target price on shares of Ardent Health Partners in a research report on Thursday, September 19th. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $22.00.

View Our Latest Report on Ardent Health Partners

Ardent Health Partners Stock Down 1.2 %

ARDT stock opened at $16.64 on Monday. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. The company has a fifty day simple moving average of $16.75. Ardent Health Partners has a 12 month low of $14.57 and a 12 month high of $20.72.

Institutional Investors Weigh In On Ardent Health Partners

A number of hedge funds have recently modified their holdings of the business. State Street Corp acquired a new stake in Ardent Health Partners in the 3rd quarter valued at about $1,977,000. Allspring Global Investments Holdings LLC purchased a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $13,119,000. Goldentree Asset Management LP acquired a new stake in shares of Ardent Health Partners in the third quarter valued at approximately $22,897,000. Franklin Resources Inc. purchased a new position in Ardent Health Partners during the third quarter worth approximately $15,839,000. Finally, Systematic Financial Management LP acquired a new position in Ardent Health Partners during the third quarter worth $595,000.

About Ardent Health Partners

(Get Free Report)

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

See Also

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.